Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormonal changes in hemodialysis.

V Bonomini1, G Orsoni, M A Sorrentino

  • 1Nephrology Institute, Sant' Orsola University Hospital, Bologna, Italy.

Blood Purification
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accurate quantification of phosphorus intergranular segregation in iron by STEM-EDX.

Micron (Oxford, England : 1993)·2021
Same author

Body mass index and metabolic syndrome impact differently on major clinical events in renal transplant patients.

European review for medical and pharmacological sciences·2017
Same author

Incidence of late deep venous thrombosis among renal transplant patients.

Transplantation proceedings·2013
Same author

Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy.

British journal of cancer·2013
Same author

From primary progressive aphasia to corticobasal syndrome: two clinical and rCBF functional reports.

Neurocase·2012
Same author

Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab.

British journal of cancer·2011
Same journal

Peritoneal Glucose Uptake Reduction by Sodium-Glucose Co-Transporter 2 Inhibitors in Clinical Peritoneal Dialysis.

Blood purification·2026
Same journal

With the Generalization of AI and Algorithms, Will We Still Need a Nephrologist in the Dialysis Room?

Blood purification·2026
Same journal

Could serum CA125 aid the clinical assessment of volume status of end-stage kidney disease patients treated by peritoneal dialysis patients?

Blood purification·2026
Same journal

From Bench to Bedside: Implications and Interventions for Endotoxin Exposure in Lipopolysaccharide-Induced Apoptosis and Eryptosis.

Blood purification·2026
Same journal

Feasibility Study of a Smartphone App and Web Portal for Remote Monitoring of Chronic Kidney Disease and Peritoneal Dialysis populations: A mixed-method study.

Blood purification·2026
Same journal

Treatment of Focal Segmental Glomerulosclerosis in Low- and Middle-Income Countries: Emerging Extracorporeal Therapies.

Blood purification·2026
See all related articles

Hormone imbalances are common in advanced chronic renal failure and often worsen with dialysis. These endocrine derangements significantly impact the overall health and metabolic recovery of patients undergoing dialysis.

Area of Science:

  • Nephrology
  • Endocrinology
  • Internal Medicine

Background:

  • Advanced chronic renal failure leads to complex hormonal alterations.
  • These changes result from impaired synthesis, transport, inhibitor accumulation, target organ resistance, and reduced renal clearance.

Purpose of the Study:

  • To summarize the key endocrine derangements in chronic renal failure.
  • To highlight the impact of these abnormalities on dialysis patients.

Main Methods:

  • Review of existing literature on endocrine dysfunction in chronic renal failure.
  • Categorization of major hormonal abnormalities observed in uremia.

Main Results:

  • Dialysis does not typically reverse uremic hormone abnormalities; some may worsen.

Related Experiment Videos

  • Key endocrine issues include sexual dysfunction, thyroid problems, growth retardation, metabolic disorders, pressor substance derangements, gastrointestinal peptide issues, renal osteodystrophy, and anemia.

    • Conclusions:

    • Endocrine abnormalities are a significant factor in the clinical and metabolic status of dialysis patients.
    • Addressing these hormonal derangements is crucial for patient rehabilitation.